MedTrace Logo

Daptomycin Concentration in Drainage Fluid and Blood Samples of ICU Patients

NCT03004066 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2019-04-19

No results posted yet for this study

Summary

10 patients with chronic heart failure receiving daptomycin therapy after implantation of a left ventricular heart assist system. Measurement of daptomycin levels in drainage fluids (mediastinal and pleural drainage systems) and in blood samples.

Conditions

  • Heart Assist Device

Interventions

DRUG

Daptomycin

standard care

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Stefanie Prohaska, MD · University Hospital Tuebingen

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03004066 on ClinicalTrials.gov